Naringin Inhibits <scp>ROS</scp>‐activated <scp>MAPK</scp> Pathway in High Glucose‐induced Injuries in H9c2 Cardiac Cells
Jingfu Chen(The First Affiliated Hospital, Sun Yat-sen University), Keng Wu(Guangdong Medical College)
Cited by 77
Related Papers
The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway
|American Journal of Physiology-Endocrinology and Metabolism|2016|74
Exogenous hydrogen sulfide exerts proliferation/anti-apoptosis/angiogenesis/migration effects via amplifying the activation of NF-κB pathway in PLC/PRF/5 hepatoma cells
|International Journal of Oncology|2015|72
Naringin protects cardiomyocytes against hyperglycemia-induced injuries in vitro and in vivo
|Journal of Endocrinology|2016|65
Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways
|Oncology Reports|2015|42
Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells
|International Journal of Molecular Medicine|2014|35